Market Tracker

01/17 5:19pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

17.98
Delayed Data
As of 4:00pm ET
 -1.76 / -8.92%
Today’s Change
10.74
Today|||52-Week Range
21.13
-11.25%
Year-to-Date
Juno's Stock High on Possible Acquisition
11:16am / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close19.74
Today’s open17.55
Day’s range17.11 - 18.17
Volume6,555,262
Average volume (3 months)1,509,160
Market cap$2.8B
Data as of 4:00pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)+132.00%
Earnings growth (next 5 years)+9.10%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.24-0.70%
BPMCBlueprint Medicines ...+2.14+2.92%
XLRNAcceleron Pharma Inc-0.03-0.07%
XONIntrexon Corp+0.48+3.49%
Data as of 4:00pm ET, 01/17/2018

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)$0.61
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts